HEALTHY AIMS - Nano scale materials and sensors and microsystems for medical implants improving health and quality of life (FP6-IST) (2003-12-01 - 2007-11-30) (»add to infobox)

Diana HODGINS, Andy WOLFF, Torsten EGGERS, Michael JACKSON, Ben KLOECK, Arnaud BERTSCH, Ioanis KATAKIS, John SPENSLEY, Thomas LINK, Holger BECKER, Piotr GRABIEC, Eric BEYNE, Robert URIE, Helge BOHLMANN, Robert Edward TURNER, Roger FENELEY, Pankaj VADGAMA, Michel BROUSSELY, Paul Nicholas TAYLOR, David PEDDER, Jens DUCREE, Kenneth SNOWDON, Laurence KENNEY, Michaela VELIKAY-PAREL, Thomas BAAL, Martin MCHUGH, N. N., N. N., N. N., N. N., N. N.

EUROPEAN TECHNOLOGY FOR BUSINESS LIMITED (UKH21 - Luton) (Great Britain), ASSUTA MEDICAL CENTERS LTD (IL - Israel) (Israel), CAMPUS MICRO TECHNOLOGIES GMBH (DE501 - Bremen, Kreisfreie Stadt) (Germany), CENTRAL RESEARCH LABORATORIES LIMITED (UK403 - Suffolk) (Great Britain), COCHLEAR EUROPE LIMITED (UK550 - Greater London) (Great Britain), ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH022 - Freiburg) (Switzerland), UNIVERSIDAD ROVIRA I VIRGILI (ES514 - Tarragona) (Spain), FINETECH MEDICAL LIMITED (UKH23 - Hertfordshire) (Great Britain), HAHN-SCHICKARD-GESELLSCHAFT FUER ANGEWANDTE FORSCHUNG E.V. (DE136 - Schwarzwald-Baar-Kreis) (Germany), IIP - TECHNOLOGIES GMBH (DEA22 - Bonn, Kreisfreie Stadt) (Germany), INSTITUTE OF ELECTRON TECHNOLOGY (PL127 - Miasto Warszawa) (Poland), INTERUNIVERSITAIR MICRO-ELECTRONICA CENTRUM VZW (BE242 - Arr. Leuven) (Belgium), MEDIPLUS LIMITED (UKJ13 - Buckinghamshire CC) (Great Britain), MICROTEC GESELLSCHAFT FUER MIKROTECHNOLOGIES MBH (DEA12 - Duisburg, Kreisfreie Stadt) (Germany), THE NEXUS ASSOCIATION (FR714 - Isère) (France), NORTH BRISTOL NATIONAL HEALTH SERVICE TRUST (UKK12 - North and North East Somerset, South Gloucestershire) (Great Britain), QUEEN MARY AND WESTFIELD COLLEGE, UNIVERSITY OF LONDON (UKI12 - Inner London - East) (Great Britain), SAFT S.A. (FR106 - Seine-Saint-Denis) (France), SALISBURY HEALTH CARE NATIONAL HEALTH SERVICE TRUST (UKK15 - Wiltshire CC) (Great Britain), TWI LIMITED (UKH12 - Cambridgeshire CC) (Great Britain), ALBERT-LUDWIGS-UNIVERSITAET FREIBURG (DE131 - Freiburg im Breisgau, Stadtkreis) (Germany), UNIVERSITY OF NEWCASTLE UPON TYNE (UKC22 - Tyneside) (Great Britain), UNIVERSITY OF SALFORD (UK820 - Greater Manchester) (Great Britain), UNIVERSITAET WIEN (AT130 - Wien) (Austria), VDI / VDE INNOVATION + TECHNIK GMBH (DE300 - Berlin) (Germany), ZARLINK SEMICONDUCTOR LIMITED (UKK14 - Swindon) (Great Britain), N / A (NoRegion - NoRegion) (NoCountry), COMMISSARIAT A L'ENERGIE ATOMIQUE (CEA) (FR101 - Paris) (France), MEDCAL UNIVERSITY OF GRAZ (AT221 - Graz) (Austria), UNIVERSITY COLLEGE LONDON (UKI11 - Inner London - West) (Great Britain), JAGIELLONIAN UNIVERSITY IIN KRAKOW (PL213 - Miasto Krakow) (Poland)

In this project key microsystem technologies and communication methods will be developed that bring intelligence directly to the human, in the form of medical implants and ambulatory measurement systems, and also enable information from these devices to be transmitted out into the wider environment. The microsystem technologies to be developed can be applied to any generic Ambient Intelligent system comprising sensors, actuators, an intelligent processor and a wiring loom. The medical applications have been chosen for 2 reasons. Firstly, they will progress the existing State of the Art in Microsystems in terms of size, reliability, and power constraints far more than many other application sectors. In addition, there will be a direct positive impact into the health of EU citizens. The overall objective is to develop the technologies that go to make up a microsystem, and then produce specific medical devices to exploit these technologies. The 4 year project, with 27 partners, is structured with the focus on the microsystem technology development, most of which does not include silicon. This is seen as crucial if complete microsystems are to be realised in the coming few years. This project includes participants from all of the disciplines necessary to produce a complete generic microsystem. The result will be a range of core technologies and medical devices utilising these core technologies. Intelligence will be given back to people where part of their own internal system has failed. Quality of life will be improved for millions of EU citizens and the long term cost of treating people will reduce significantly. The resulting final medical products include cochlear and retina implants, nerve stimulation, bladder control and pressure monitoring systems. It is estimated from the available statistics that around 50% of the western population i.e. around 500 million citizens, will suffer from at least one of the health problems targeted in this project.

PERSONS (31/31)

RELATED NAVIGATION AREA(S) (2/2)